Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03708211
What this trial is testing

Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms, Advanced Solid
Millennium Pharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Early research (Phase 1)Study completedNCT04855929
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

Who this might be right for
Advanced Solid TumorAdult DiseaseLung Cancer
Anaveon AG 55
Testing effectiveness (Phase 2)Study completedNCT04082572
What this trial is testing

Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers

Who this might be right for
Locally Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT03508011
What this trial is testing

IMP4297 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumoursBreast CancerOvarian Cancer+1 more
Impact Therapeutics, Inc. 57
Early research (Phase 1)Study completedNCT03536728
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+1 more
Aminex Therapeutics, Inc. 56
Early research (Phase 1)Study completedNCT05075564
What this trial is testing

ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
Elpiscience Biopharma, Ltd. 8
Testing effectiveness (Phase 2)Looking for participantsNCT02029001
What this trial is testing

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Who this might be right for
Malignant Solid Neoplasms
Centre Leon Berard 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865
What this trial is testing

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 49
Early research (Phase 1)Active Not RecruitingNCT06428500
What this trial is testing

QTX3046 in Patients With KRAS G12D Mutations

Who this might be right for
Advanced Solid Tumor
Quanta Therapeutics 240
Testing effectiveness (Phase 2)Looking for participantsNCT07192107
What this trial is testing

MHB042C in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Early research (Phase 1)Study completedNCT01299636
What this trial is testing

Study of PM060184 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
PharmaMar 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04919811
What this trial is testing

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Nuvation Bio Inc. 217
Testing effectiveness (Phase 2)Study completedNCT01897571
What this trial is testing

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Who this might be right for
B-cell Lymphomas (Phase 1)Advanced Solid Tumors (Phase 1)Diffuse Large B-cell Lymphoma (Phase 2)+3 more
Epizyme, Inc. 400
Early research (Phase 1)Study completedNCT02481154
What this trial is testing

Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation

Who this might be right for
Glioma
Institut de Recherches Internationales Servier 95
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Early research (Phase 1)Study completedNCT04147234
What this trial is testing

Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)

Who this might be right for
Neoplasms
Boehringer Ingelheim 42
Early research (Phase 1)UnknownNCT05370755
What this trial is testing

ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd. 22
Next Page